PrEPTECH
Funder
Gilead Sciences
Funding Duration
September 2019 - March 2022
PL
Bhupendra Sheoran
Description
PrEPTECH, an online program and research study, is an integrated tech approach to increasing pre-exposure prophylaxis (PrEP) uptake among young gay and bisexual men. In 2012, the US Food and Drug Administration approved daily oral pre-exposure prophylaxis medication to prevent HIV infection in high-risk individuals, which offered a unique opportunity to curb the rising incidence of HIV infection in high-risk groups, particularly among young men who have sex with men (YMSM).
Working closely with the community, YTH co-designed the PrEPTECH online web program to support the uptake and adherence of PrEP, while allowing users to bypass many of the barriers related to stigma, discrimination, and access. The multisite study aims to evaluate the PrEPTECH online program, and provide important PrEP access and care to a variety of community members including young gay and bisexual men, adolescents and transgender women.
Website
Citations
Refugio, O. N., Kimble, M. M., Silva, C. L., Lykens, J. E., Bannister, C., & Klausner, J. D. (2019). Brief Report: PrEPTECH: A Telehealth-Based Initiation Program for HIV Pre-exposure Prophylaxis in Young Men of Color Who Have Sex With Men. A Pilot Study of Feasibility. JAIDS Journal of Acquired Immune Deficiency Syndromes, 80(1). Retrieved from https://journals.lww.com/jaids/Fulltext/2019/01010/Brief_Report__PrEPTECH__A_Telehealth_Based.9.aspx
